References
- Kitano Y., Ikeda N., Okano M. Suppression of proliferation of human epidermal keratinocytes by 1,25‐dihydroxyvitamin D3. Analysis of its effect on psoriatic lesion and of its mechanism using human keratinocytes in culture. Eur J Clin Invest 1991; 21: 53–8
- Smith E. L., Walworth N. C., Holick M. F. Effect of 1 alpha,25‐dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum‐free conditions. J Invest Dermatol 1986; 86: 709–14
- Kragballe K. Treatment of psoriasis with calcipotriol and other vitamin D analogues. J Am Acad Dermatol 1992; 27((6 Pt 1))1001–8
- Dubertret L., Wallach D., Souteyrand P., Perussel M., Kalis B., Meynadier J., et al. Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. A randomized, double‐blind, right/left comparative, vehicle‐controlled study. J Am Acad Dermatol 1992; 27((6 Pt 1))983–8
- Lebwohl M., Siskin S. B., Epinette W., Breneman D., Funicella T., Kalb R., et al. A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis. J Am Acad Dermatol 1996; 35((2 Pt 1))268–9
- Papp K., Guenther L., Boyden B., Larsen F., Harvima R., Guilhou J., et al. Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J Am Acad Dermatol 2003; 48: 48–54
- Lebwohl M. Topical application of calcipotriene and corticosteroids: Combination regimens. J Am Acad Dermatol 1997; 37((3 Pt 2))S55–8
- Speight E. L., Farr P. M. Calcipotriol improves the response of psoriasis to PUVA. Br J Dermatol 1994; 130: 79–82
- Lehmann P., Kerscher M. Combination phototherapy of psoriasis with calcipotriene and narrow‐band (311 nm) UVB [letter; comment]. J Am Acad Dermatol 1997; 36((3 Pt 1))501–2
- Hecker D., Lebwohl M. Topical calcipotriene in combination with UVB phototherapy for psoriasis. Int J Dermatol 1997; 36: 302–3
- Pearce D. J., Stealey K. H., Balkrishnan R., Fleischer A. B Jr., Feldman S. R. Psoriasis treatment in the United States at the end of the 20th century. Int J Dermatol 2006; 45: 370–4
- Berth‐Jones J., Bourke J., Bailey K., Graham‐Brown R. A., Hutchinson P. E. Generalised pustular psoriasis: response to topical calcipotriol [see comments]. BMJ 1992; 305: 868–9
- Piraccini B. M., Tosti A., Iorizzo M., Misciali C. Pustular psoriasis of the nails: Treatment and long‐term follow‐up of 46 patients. Br J Dermatol 2001; 144: 1000–5
- Van der Vleuten C. J., Gerritsen M. J., Steijlen P. M., De Jong E. M., Van de Kerkhof P. C. A therapeutic approach to erythrodermic psoriasis: Report of a case and a discussion of therapeutic options. Acta Derm Venereol 1996; 76: 65–7
- Bohm M., Luger T. A., Metze D. Treatment of mixed‐type acanthosis nigricans with topical calcipotriol. Br J Dermatol 1998; 139: 932–4
- Lucker G. P., Van de Kerkhof P. C., van Dijk M. R., Steijlen P. M. Effect of topical calcipotriol on congenital ichthyoses. Br J Dermatol 1994; 131: 546–50
- Scott‐Mackie P., Hickish T., Mortimer P., Sloane J., Cunningham D. Calcipotriol and regression in T‐cell lymphoma of skin. Lancet 1993; 342: 172
- Gniadecki R. Calcipotriol for erythema annulare centrifugum. Br J Dermatol 2002; 146: 317–19
- Van de Kerkhof P. C., Steijlen P. M. Topical treatment of pityriasis rubra pilaris with calcipotriol. Br J Dermatol 1994; 130: 675–8
- National Ambulatory Medical Care Survey. Division of Health Care Statistics, National Center for Health Statistics, Centers for Disease Control and Prevention. June 17 2003. US National Center for Health Statistics. Available at: http://www.cdc.gov/nchs/about/major/ahcd/namcsdes.htm
- Feldman S. R., Williford P. M., Fleischer A. B Jr. Lower utilization of dermatologists in managed care: despite growth in managed care, visits to dermatologists did not decrease: an analysis of National Ambulatory Medical Care Survey data, 1990–1992. J Invest Dermatol 1996; 107: 860–4
- Sugarman J. H., Fleischer A. B Jr., Feldman S. R. Off‐label prescribing in the treatment of dermatologic disease. J Am Acad Dermatol 2002; 47: 217–23
- Gargoom A. M., Duweb G. A., Elzorghany A. H., Benghazil M., Bugrein O. O. Calcipotriol in the treatment of childhood vitiligo. Int J Clin Pharmacol Res 2004; 24: 11–14